Alpha 2.0
Login Register
» Authors » Hasan Ilkova

Hasan Ilkova

Explore the profile of Hasan Ilkova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 750
Followers 0
Related Specialties
Endocrinology
General Medicine
Genetics
Top 10 Co-Authors
Jean-Marc Chantelot
Pablo Aschner
Ambady Ramachandran
Jean Claude Mbanya
Tulay Akcay
Yildiz Dincer
Taner Damci
Juliana C N Chan
Marina Shestakova
Juan Jose Gagliardino
Published In
Diabetes Care
Diabetes Res Clin Pract
Diabetologia
N Engl J Med
Obes Facts
Affiliations
Soon will be listed here.
Recent Articles
1.
Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study
Chan J, Mbanya J, Chantelot J, Shestakova M, Ramachandran A, Ilkova H, et al.
J Diabetes Investig . 2024 Jun; 15(9):1306-1316. PMID: 38840439
Aims/introduction: We analyzed patient-reported outcomes of people with type 2 diabetes to better understand perceptions and experiences contributing to treatment adherence. Materials And Methods: In the ongoing International Diabetes Management...
2.
Status of Weight Change, Lifestyle Behaviors, Depression, Anxiety, and Diabetes Mellitus in a Cohort with Obesity during the COVID-19 Lockdown: Turk-Com Study Group
Yazici D, Fersahoglu M, Fersahoglu T, Esen Bulut N, Cigiltepe H, Celer O, et al.
Obes Facts . 2022 May; 15(4):528-539. PMID: 35545017
Introduction: The coronavirus disease 2019 (COVID-19) pandemic led to a lockdown period. Confinement periods have been related to unhealthy lifestyle behaviors. Our study aimed to determine weight change, changes in...
3.
Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice
Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, et al.
Front Endocrinol (Lausanne) . 2022 Feb; 12:663222. PMID: 35140679
This expert panel of diabetes specialists aimed to provide guidance to healthcare providers on the best practice in the use of innovative continuous glucose monitoring (CGM) techniques through a practical...
4.
The Role of Obesity in Predicting the Clinical Outcomes of COVID-19
Sahin S, Sezer H, Cicek E, Ozogul Y, Yildirim M, Icli T, et al.
Obes Facts . 2021 Aug; 14(5):481-489. PMID: 34352797
Introduction: The aim of this was to describe the predictors of mortality related to COVID-19 infection and to evaluate the association between overweight, obesity, and clinical outcomes of COVID-19. Methods:...
5.
One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)
Chan J, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A, Mbanya J, et al.
Adv Ther . 2021 May; 38(6):3281-3298. PMID: 33978906
Introduction: Although poor adherence to insulin is widely recognised, periodic discontinuation of insulin may cause more severe hyperglycaemia than poor adherence. We assessed persistence with insulin therapy in patients with...
6.
High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study
Aschner P, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A, Mbanya J, et al.
Diabetes Care . 2021 May; 44(5):1100-1107. PMID: 33963019
Objective: Depression is common in people with diabetes, but data from developing countries are scarce. We evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using...
7.
Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005-2017): the International Diabetes Management Practices Study (IDMPS)
Mbanya J, Aschner P, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A, et al.
Diabetologia . 2021 Feb; 64(6):1246-1255. PMID: 33594476
Aims/hypothesis: Diabetes is the leading cause of kidney disease worldwide. There is limited information on screening, treatment and control of kidney disease in patients with diabetes in low-to-middle-income countries (LMICs)....
8.
Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries
Vaxillaire M, Bonnefond A, Liatis S, Ben Salem Hachmi L, Jotic A, Boissel M, et al.
Diabetes Res Clin Pract . 2020 Nov; 171:108553. PMID: 33242514
Background: Diagnosis of monogenic diabetes has important clinical implications for treatment and health expenditure. However, its prevalence remains to be specified in many countries, particularly from South Europe, North Africa...
9.
Correction to: Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)
Aschner P, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A, Mbanya J, et al.
Diabetologia . 2020 Mar; 63(5):1088-1089. PMID: 32140743
Unfortunately, the standard deviations for 'last HbA measurement' in mmol/mol were miscalculated in Table 1 of this paper.
10.
Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)
Aschner P, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A, Mbanya J, et al.
Diabetologia . 2020 Jan; 63(4):711-721. PMID: 31901950
Aims/hypothesis: We evaluated the secular trend of glycaemic control in individuals with type 2 diabetes in developing countries, where data are limited. Methods: The International Diabetes Management Practices Study provides...